Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-06-14

Clinical Trial Update: The Effect of Alogliptin on Pulmonary Function in Obese Patients With Type 2 Diabetes Inadequately Controlled by Metformin Monotherapy [NA]

View source ↗

Summary

This clinical trial update notes a completed study evaluating the effect of alogliptin on pulmonary function in obese patients with type 2 diabetes inadequately…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Alogliptin (alogliptin)

Snippet

Sponsor: Fourth People's Hospital of Shenyang | Conditions: Diabetes Mellitus, Type 2 | NA | Status: COMPLETED